📰 Prosight Management News
Page 3 - Prosight Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prosight Management. Real-time updates on events, politics, business and more.
September 7, 2023
Prosight Management LP lifted its holdings in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 603.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,257,360 shares of the company’s stock after purchasing an additional 2,794,050 shares during the quarter. ADC Therapeutics accounts for […]
September 7, 2023
Prosight Management LP lowered its holdings in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 7.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 316,165 shares of the company’s stock after selling 25,356 shares during the period. Alkermes comprises about 4.2% of Prosight […]
September 7, 2023
Prosight Management LP cut its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 61.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 240,000 shares of the specialty pharmaceutical company’s stock after selling 381,667 shares during the quarter. KalVista Pharmaceuticals comprises […]
September 7, 2023
Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $8.00 target price on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 436.91% from the company’s previous close. […]
September 7, 2023
Prosight Management LP purchased a new position in Erasca, Inc. (NASDAQ:ERAS – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor purchased 1,179,090 shares of the company’s stock, valued at approximately $3,549,000. Erasca makes up about 1.7% of Prosight Management LP’s holdings, making the stock its 26th largest holding. Other hedge funds and […]
August 24, 2023
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Investment analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Nuvation Bio in a research note issued on Monday, August 21st. HC Wainwright analyst R. Burns anticipates that the company will post earnings of ($0.11) per share for the quarter. HC Wainwright […]
July 17, 2023
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a large growth in short interest in June. As of June 30th, there was short interest totalling 732,800 shares, a growth of 165.2% from the June 15th total of 276,300 shares. Approximately 5.2% of the company’s stock are short sold. Based on an […]
July 15, 2023
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 732,800 shares, an increase of 165.2% from the June 15th total of 276,300 shares. Currently, 5.2% of the company’s shares are short sold. […]
June 15, 2023
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 202,400 shares, a growth of 149.9% from the May 15th total of 81,000 shares. Approximately 1.4% of the company’s shares are sold short. Based […]
June 14, 2023
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 202,400 shares, an increase of 149.9% from the May 15th total of 81,000 shares. Based on an average daily volume of 90,000 shares, the […]